Eculizumab for Pediatric Hematopoietic Cell Transplant–Associated Thrombotic Microangiopathy: Real-World Response Rates, Predictors of Poor Response, and an Optimal Time Point for Treatment Response Assessment
Year: 2026
Type: article
Study design: Observational Study
Authors: Michelle L. Schoettler, Geoffrey Cheng, Christine S. Higham, Christopher C. Dvorak, Cassandra Rush, Hemalatha G. Rangarajan, Majed Al-Nazer, Veronika Polishchuk, Sonali Chaudhury, Leslie Lehmann, Christine Duncan, Miki Nishitani, Haig Manougian, Seth Rotz, Joel Ofori, Erin Frost, Jeremy Orbodo, Kathleen Spencer, Ellen Kenney, Satheesh Chonat, Joseph Chewning, Caitlin Moore, Adrianna Westbrook, Kirsten M. Williams
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W7155489043